Nomic is developing the world’s highest-throughput proteomic platform, the nELISA™. Using DNA nanotechnology, spectral multiplexing, and automation, the nELISA transforms the traditional sandwich immunoassay into a massively multiplexed protein profiling tool without compromising throughput, cost, or fidelity. Today we're offering scientists the fastest and most flexible protein profiling solutions to empower them to deign their experiments at scale. Working with top pharmas and research institutes, we are bringing the power of high-content proteomics to high-throughput drug discovery. For more information, visit nomic.bio